Global In Vitro Diagnostics Market US$ 88 Billion by 2021

Global In Vitro Diagnostics Market US$ 88 Billion by 2021

In Vitro Diagnostics Market – Global Clinical Applications Analysis and Forecast 2017-2021, estimates the global in vitro diagnostics market to reach nearly US$ 82.7 Billion in 2020, at a CAGR of 6.5% from 2017 to 2021 – iHealthcareAnalyst, Inc.

Visit the In Vitro Diagnostics Market – Global Clinical Applications Analysis and Forecast 2017-2021 report

In Vitro Diagnostics (IVD) is an important segment in the global healthcare industry. The diagnostic tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. The marketplace is witnessing rapid growth fueled by technological advancements, better diagnostic tools, and improved treatment monitoring, and increased availability of over-the-counter tests. The global in vitro diagnostics market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market and also forecasts growth trends (CAGR% – 2017 to 2021). It also covers the major companies operating in the market and provides detailed analysis of the different clinical applications such as blood screening, diabetes, immunology, and molecular diagnostics in the global market.

The global in vitro diagnostics market is segmented as:

  1. Clinical Application
    • Blood Testing
    • Clinical Chemistry
    • Diabetes Testing
    • Immunoassay
    • Molecular Diagnostics
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories, Inc
    • Alere, Inc.
    • Bayer AG
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • Biomerieux SA
    • Hoffmann-La Roche Ltd
    • Life Technologies Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific, Inc

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]

2017-11-05T19:04:54+00:00 Categories: Press Releases|